CaĆete, Alex D.
HRN: 25-85-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
MUPIROCIN 2%, 15G (TUBE)
10/30/2024
11/08/2024
TOPICAL
To Affected Area
BID
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes